Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 794 across all filing types
Latest filing 2022-01-06 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2021. It is a short letter addressed to stock exchanges confirming regulatory compliance, issued by the Registrar and Transfer Agent. There is no financial data, no detailed report, and the document is primarily a certification. According to the Certification Rule, such documents are classified as Regulatory Filings (RNS). The document length is short (1563 characters), and it is not a report itself but a compliance certificate.
2022-01-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window due to upcoming unaudited financial results for the quarter and nine months ended December 31, 2021. It references the upcoming announcement of financial results but does not contain any financial data or the results themselves. The document is only 1726 characters long and serves as an announcement related to compliance with insider trading regulations. Therefore, it is not a financial report or earnings release but a regulatory filing informing about trading restrictions ahead of financial disclosures.
2021-12-31 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a communication addressed to stock exchanges and depositories regarding the details of shares dematerialized during November 2021. It references Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, and includes a certificate from the Registrar and Transfer Agent (RTA) confirming the dematerialized shares. The document is informational and regulatory in nature, providing compliance details rather than financial results, management changes, or shareholder meeting information. It does not contain financial statements or detailed analysis, nor is it a report or presentation. Given the nature and length (3072 characters), it is a regulatory announcement related to share dematerialization status, fitting best under Regulatory Filings (RNS).
2021-12-06 English
Price movement
Regulatory Filings Classification · 95% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information. Given the lack of content, this cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or empty filings.
2021-12-02 English
Updates
Regulatory Filings Classification · 90% confidence The document text is extremely short (54 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement of a report. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2021-11-18 English
Copy of Newspaper Publication
Regulatory Filings
2021-11-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.